This page lists the SEC filings reported by Nan Fung Group Holdings Ltd.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2022-12-16 | Nan Fung Group Holdings Ltd | Eargo, Inc. | 2,958,099 | 0.7% | EDGAR |
| SC 13D | 2020-10-29 | Nan Fung Group Holdings Ltd | Eargo, Inc. | 2,886,724 | 7.7% | EDGAR |
| SC 13D/A | 2020-01-09 | Nan Fung Group Holdings Ltd | Stealth BioTherapeutics Corp | 20,240,817 | 4.8% | EDGAR |
| SC 13D | 2020-01-02 | Nan Fung Group Holdings Ltd | New Frontier Health Corp | 9,650,000 | 7.3% | EDGAR |
| SC 13D/A | 2019-12-31 | Nan Fung Group Holdings Ltd | Stealth BioTherapeutics Corp | 24,240,813 | 5.8% | EDGAR |
| SC 13D | 2019-07-15 | Nan Fung Group Holdings Ltd | Stealth BioTherapeutics Corp | 30,240,813 | 7.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.